CytomX Therapeutics, Inc. (CTMX) A Top Healthcare Penny Stock Amid Colorectal Cancer Treatment Progress [Yahoo! Finance]
CytomX Therapeutics (CTMX) Making Progress on Key Metastatic Colorectal Cancer Treatment [Yahoo! Finance]
CytomX Therapeutics (CTMX) Gains Analyst Confidence on Trial Progress [Yahoo! Finance]
CytomX Therapeutics (CTMX) had its price target raised by Piper Sandler from $10.00 to $12.00. They now have an "overweight" rating on the stock.
A Look At CytomX Therapeutics (CTMX) Valuation After Positive Varsetatug Masetecan Phase 1 Expansion Results [Yahoo! Finance]